These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12067440)

  • 1. The epidermis as a bioreactor: topically regulated cutaneous delivery into the circulation.
    Cao T; Tsai SY; O'Malley BW; Wang XJ; Roop DR
    Hum Gene Ther; 2002 Jun; 13(9):1075-80. PubMed ID: 12067440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulated cutaneous gene delivery: the skin as a bioreactor.
    Cao T; Wang XJ; Roop DR
    Hum Gene Ther; 2000 Nov; 11(16):2297-300. PubMed ID: 11084689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic studies with a keratin promoter-driven growth hormone transgene: prospects for gene therapy.
    Wang X; Zinkel S; Polonsky K; Fuchs E
    Proc Natl Acad Sci U S A; 1997 Jan; 94(1):219-26. PubMed ID: 8990189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonviral transfer of genes to pig primary keratinocytes. Induction of angiogenesis by composite grafts of modified keratinocytes overexpressing VEGF driven by a keratin promoter.
    Rio MD; Larcher F; Meana A; Segovia J; Alvarez A; Jorcano J
    Gene Ther; 1999 Oct; 6(10):1734-41. PubMed ID: 10516723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increases in weight of growth hormone-deficient and immunodeficient (lit/scid) dwarf mice after grafting of hGH-secreting, primary human keratinocytes.
    Bellini MH; Peroni CN; Bartolini P
    FASEB J; 2003 Dec; 17(15):2322-4. PubMed ID: 14525947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAXI/UAS: A molecular switch to control expression of genes in vivo.
    Delort JP; Capecchi MR
    Hum Gene Ther; 1996 May; 7(7):809-20. PubMed ID: 8860833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating human factor IX produced in keratin-promoter transgenic mice: a feasibility study for gene therapy of haemophilia B.
    Alexander MY; Bidichandani SI; Cousins FM; Robinson CJ; Duffie E; Akhurst RJ
    Hum Mol Genet; 1995 Jun; 4(6):993-9. PubMed ID: 7544665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preclinical model for the analysis of genetically modified human skin in vivo.
    Del Rio M; Larcher F; Serrano F; Meana A; Muñoz M; Garcia M; Muñoz E; Martin C; Bernad A; Jorcano JL
    Hum Gene Ther; 2002 May; 13(8):959-68. PubMed ID: 12031128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of gene-switch transgenic mice that inducibly express transforming growth factor beta1 in the epidermis.
    Wang XJ; Liefer KM; Tsai S; O'Malley BW; Roop DR
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8483-8. PubMed ID: 10411901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tyrosine hydroxylase-human growth hormone (GH) transgenic mouse as a model of hypothalamic GH deficiency: growth retardation is the result of a selective reduction in somatotrope numbers despite normal somatotrope function.
    Kineman RD; Aleppo G; Frohman LA
    Endocrinology; 1996 Nov; 137(11):4630-6. PubMed ID: 8895326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal differentiation and keratin gene expression.
    Fuchs E
    Princess Takamatsu Symp; 1994; 24():290-302. PubMed ID: 8983083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic control of a humanized gene therapy system implanted into nude mice.
    Magari SR; Rivera VM; Iuliucci JD; Gilman M; Cerasoli F
    J Clin Invest; 1997 Dec; 100(11):2865-72. PubMed ID: 9389753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratinocyte-specific expression of human thrombomodulin in transgenic mice: effects on epidermal differentiation and cutaneous wound healing.
    Raife TJ; Lager DJ; Peterson JJ; Erger RA; Lentz SR
    J Investig Med; 1998 Apr; 46(4):127-33. PubMed ID: 9635371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin genetically engineered as a bioreactor or a 'metabolic sink'.
    Christensen R; Jensen UB; Jensen TG
    Cells Tissues Organs; 2002; 172(2):96-104. PubMed ID: 12426486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor binding protein-3 (IGFBP-3) localizes to and modulates proliferative epidermal keratinocytes in vivo.
    Edmondson SR; Thumiger SP; Kaur P; Loh B; Koelmeyer R; Li A; Silha JV; Murphy LJ; Wraight CJ; Werther GA
    Br J Dermatol; 2005 Feb; 152(2):225-30. PubMed ID: 15727632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted overexpression of leptin to keratinocytes in transgenic mice results in lack of skin phenotype but induction of early leptin resistance.
    Rico L; Del Rio M; Bravo A; Ramirez A; Jorcano JL; Page MA; Larcher F
    Endocrinology; 2005 Oct; 146(10):4167-76. PubMed ID: 15994350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis.
    Haase I; Hobbs RM; Romero MR; Broad S; Watt FM
    J Clin Invest; 2001 Aug; 108(4):527-36. PubMed ID: 11518726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term regulated expression of growth hormone in mice after intramuscular gene transfer.
    Rivera VM; Ye X; Courage NL; Sachar J; Cerasoli F; Wilson JM; Gilman M
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8657-62. PubMed ID: 10411931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
    Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
    Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seminal vesicle production and secretion of growth hormone into seminal fluid.
    Dyck MK; Gagné D; Ouellet M; Sénéchal JF; Bélanger E; Lacroix D; Sirard MA; Pothier F
    Nat Biotechnol; 1999 Nov; 17(11):1087-90. PubMed ID: 10545914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.